Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

This Is What Whales Are Betting On Diamondback Energy

A whale with a lot of money to spend has taken a noticeably bullish stance on Diamondback Energy. Looking at options history for Diamondback Energy (NASDAQ:FANG) we detected 10 strange trades.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2022

Upgrades

Benzinga

Amazon Halts Delivery Bots; Merck's Covid-19 Pill Didn't Reduce Risk; Samsung Profits Slip; Adidas Reviews Relationship With Kanye: Top Stories Friday, Oct. 7

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Coinbase Global And 3 Other Stocks Insiders Are Buying

Although US stocks closed lower on Thursday, there were a few notable insider trades.

Benzinga

AMD, Samsung's Warnings Underline Looming Tech Slowdown — But This Analyst Sees Pockets Of Strength

Advanced Micro Devices Inc. (NASDAQ: AMD) shares moved sharply to the downside in after-hours trading on Thursday after the chipmaker warned of a revenue shortfall.

Benzinga

Without 'The Apprentice' There Would Be No President Trump: New Book Details How Reality TV Helped Him Win In 2016

In her newly released book, “Confidence Man: The Making of Donald Trump and the Breaking of America," author Maggie Haberman recalls how the reality TV show “The Apprentice” helped shape the way voters saw former President Donald Trump.

Benzinga

Poshmark Buyout Offer Falls Well Below IPO Price: Analysts Call It Fair — Is It?

When South Korean tech giant Naver confirmed earlier this week that it would purchase Poshmark Inc. (NASDAQ: POSH) at $17.90 per share, many observers said the offer was fair.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Tesla Model S Vs. Lucid Air: This Race Is A Photo Finish

Car experts at Edmunds have compared Tesla Inc's (NASDAQ: TSLA) Model S Plaid to EV competitor Lucid Group Inc's (NASDA

Benzinga

Why Avenue Therapeutics Is Trading Lower By 59%; Here Are 31 Stocks Moving Premarket

Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares rose 42.3% to $11.36 in pre-market trading after jumping 83% on Thursday.

Benzinga

Nasdaq, S&P Futures Show Indecision Ahead Of Jobs Data — AMD, Peers, Credit Suisse, Cannabis Stocks In Focus

U.S. stocks are poised to open mixed on Friday, although sentiment could change markedly following the release of the September jobs report. Tech stocks could underperform in the session, weighed down by a couple of high-profile tech warnings.

Benzinga

Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday

Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday.

Benzinga

US Stock Futures Mixed; All Eyes On Jobs Report

Pre-open movers U.S. stock futures traded mixed in early pre-market trade on Friday after the Dow Jones dropped more than 300 points in the previous session. Investors are awaiting the nonfarm payrolls data for the month of September.

Benzinga

Alibaba Sheds 1%, Nio, EV Peers Tank Over 6%: Hong Kong Stocks Open Lower As Focus Turns To US Jobs Data

Hong Kong stocks opened in the red on Friday ahead of the release of the U.S.

Benzinga

Is Elon Musk A Winner Or Loser If He Acquires Twitter? 41% Of Benzinga Followers Say...

Months after Elon Musk walked away from his original $44 billion buyout proposal for Twitter Inc (NYSE: TWTR), it was reported on Tuesday that the Tesla Inc (NASDAQ:

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

General Motors 'Marching Towards An Electric Future': Former Tesla Executive Joins Company

The battle between electric vehicle leader Tesla Inc (NASDAQ: TSLA) and other traditional gas-powered traditional automakers is expected to heat up in coming years. Now, a former Tesla executive has jumped on board with a future rival.

Benzinga

What Are Whales Doing With Marvell Tech

Someone with a lot of money to spend has taken a bullish stance on Marvell Tech (NASDAQ:MRVL). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Looking At Lululemon Athletica's Recent Whale Trades

Someone with a lot of money to spend has taken a bullish stance on Lululemon Athletica (NASDAQ:LULU). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Dow Dips Over 300 Points; Provention Bio Shares Spike Higher

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 300 points on Thursday.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Mizuho Analyst Remains Bullish On The EV Sector; Finds Rivian Better Positioned

Mizuho analyst Vijay Rakesh reiterated his Buy ratings on Rivian Automotive, Inc (NASDAQ:RIVN) and the $65 price target. He saw RIVN as a pure play and a strong early mover in the EV market, focusing on the higher-growth SUV and light truck market and a robust commercial vehicle roadmap beginning with Amazon.Com, Inc. (NASDAQ:AMZN). Rivian is…

Benzinga

Selling Tesla Shares To Buy Twitter Is 'Giving Away Caviar To Buy A $2 Slice Of Pizza," Analyst Says

An analyst is using a food analogy to describe the potential of the world’s richest man needing help to finance his acquisition by selling shares of leading electric vehicle company Tesla Inc (NASDAQ: TSLA).

StockNews.com

2 Beaten-Down Nasdaq Stocks to Avoid

The NASDAQ Composite has been facing significant turmoil due to successive rate hikes. As recessionary fears loom over the economy, beaten-down stocks DraftKings (DKNG) and Affirm Holdings (AFRM) might be best avoided until further notice. Read more….

Benzinga

Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session

Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of Radiation-Related Disorders."

Benzinga

Looking At Costco Wholesale's Recent Whale Trades

Someone with a lot of money to spend has taken a bullish stance on Costco Wholesale (NASDAQ:COST). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Nasdaq Edges Higher; AngioDynamics Shares Plummet

U.S. stocks pared losses midway through trading, with the Nasdaq Composite turning higher on Thursday.

Benzinga

Asia Innovations SPAC Listing: Based in Singapore, But Made in China

Key Takeaways: Developing markets social media company Asia Innovations is planning a U.S. SPAC listing that could provide it with up to $350 million in new funds Company could represent a new generation of founding teams with Chinese roots setting up internet companies in Singapore to avoid stricter Chinese regulations

1 … 263 264 265 266

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.